Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04846504 · ClinicalTrials.gov registry record · NA
Accelerating Implementation of Mindful Mood Balance for Moms
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 423
- Enrollment target
NCT04846504: Completed NA study, sponsored by Kaiser Permanente.
NCT04846504 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 423 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04846504, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 423 participants
- Enrollment target
Study Summary
The Mindful Mood Balance for Moms (MMBFM) study examines whether using an internet program called Mindful Mood Balance for Moms to deliver Mindfulness Based Cognitive Therapy (MBCT) over an 8-week time period, is effective for reducing depression symptoms among pregnant women with a history of prior depression, and studies the effects of implementation strategies on the reach of the MMBFM program. This study will enroll 470 women from Kaiser Permanente Colorado, Southern California, Georgia. The investigators will compare clinical outcomes between those that receive mental health clinician coaching and those that receive peer coaching throughout the 8-week program. Survey data will be collected at 4 time points throughout the study (baseline, 12 weeks, 3rd trimester, and 3 months postpartum). The cost-effectiveness of both the clinical and peer coaching models at each health care system will be evaluated. For the implementation portion of the study, 30 OB clinics across the 4 health systems will be randomized in equal numbers to provide clinician facing implementation strategies (e.g., recruitment flyers, script pads, electronic medical record prompts) to encourage engagement in the MMBFM program or to usual care where women are only recruited by the study team with no clinician involvement. The primary outcome for testing clinician facing implementation strategies is reach, the percentage of women outreached who initially engage in the MMBFM program.
Primary Outcome
Depression symptom severity, scores range from 0 (low) to 27 (high)
Interventions
- BEHAVIORAL MMBFM program with clinician coach support
- BEHAVIORAL MMBFM program with peer coach support
- BEHAVIORAL Patient facing strategy intervention arm
- BEHAVIORAL Patient facing plus clinic facing strategy intervention arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 423 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2023-08-30 |
| Phase | NA |
What the finished NCT04846504 record still lists
NCT04846504 is an interventional study that assigns participants to a tested intervention. The registered 423 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 4 interventions - of which MMBFM program with clinician coach support is the first listed.
NCT04846504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04846504 about?
NCT04846504 is a clinical study titled "Accelerating Implementation of Mindful Mood Balance for Moms". The Mindful Mood Balance for Moms (MMBFM) study examines whether using an internet program called Mindful Mood Balance for Moms to deliver Mindfulness Based Cognitive Therapy (MBCT) over an 8-week time period, is effective for reducing depression symptoms among pregnant women with a history of prior...
What is the current status of trial NCT04846504?
This trial is currently completed. It is a NA study. The enrollment target is 423 participants. The study started on 2021-09-27. Estimated completion is 2023-08-30.
What interventions are being tested in trial NCT04846504?
The interventions under investigation include: MMBFM program with clinician coach support (BEHAVIORAL), MMBFM program with peer coach support (BEHAVIORAL), Patient facing strategy intervention arm (BEHAVIORAL), Patient facing plus clinic facing strategy intervention arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT04846504?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04846504's enrollment target sits among peer trials
423 238th of 2000 higher than 1,763 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06935591 · 423 participants · NA
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
- NCT07128628 · 423 participants · Phase 2
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI